Two Different Regimens of Misoprostol in Retained Placenta
Status:
Completed
Trial end date:
2019-02-14
Target enrollment:
Participant gender:
Summary
This study evaluates intra umbilical vein injection of 800 µg versus 400 µg misoprostol for
the treatment of retained placenta to reduce the need of manual removal of placenta under
general anaesthesia